Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 2
1958 2
1959 2
1960 1
1961 1
1963 1
1964 2
1965 2
1967 1
1968 2
1969 2
1971 2
1972 1
1973 1
1975 1
1980 1
1981 3
1982 1
1986 1
1987 1
1988 1
1990 4
1991 2
1993 2
1994 2
1995 1
1996 2
1997 1
1998 4
2000 2
2001 3
2002 1
2003 3
2004 3
2005 3
2006 8
2007 6
2008 6
2009 9
2010 8
2011 11
2012 10
2013 10
2014 5
2015 6
2016 10
2017 9
2018 7
2019 5
2020 4
2021 8
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
Vergote I, Van Nieuwenhuysen E, O'Cearbhaill RE, Westermann A, Lorusso D, Ghamande S, Collins DC, Banerjee S, Mathews CA, Gennigens C, Cibula D, Tewari KS, Madsen K, Köse F, Jackson AL, Boere IA, Scambia G, Randall LM, Sadozye A, Baurain JF, Gort E, Zikán M, Denys HG, Ottevanger N, Forget F, Mondrup Andreassen C, Eaton L, Chisamore MJ, Viana Nicacio L, Soumaoro I, Monk BJ. Vergote I, et al. Among authors: jackson al. J Clin Oncol. 2023 Dec 20;41(36):5536-5549. doi: 10.1200/JCO.23.00720. Epub 2023 Aug 31. J Clin Oncol. 2023. PMID: 37651655 Free PMC article. Clinical Trial.
Disparities in the analysis of morphological disparity.
Guillerme T, Cooper N, Brusatte SL, Davis KE, Jackson AL, Gerber S, Goswami A, Healy K, Hopkins MJ, Jones MEH, Lloyd GT, O'Reilly JE, Pate A, Puttick MN, Rayfield EJ, Saupe EE, Sherratt E, Slater GJ, Weisbecker V, Thomas GH, Donoghue PCJ. Guillerme T, et al. Among authors: jackson al. Biol Lett. 2020 Jul;16(7):20200199. doi: 10.1098/rsbl.2020.0199. Epub 2020 Jul 1. Biol Lett. 2020. PMID: 32603646 Free PMC article. Review.
Navigating the complexity of ecological stability.
Donohue I, Hillebrand H, Montoya JM, Petchey OL, Pimm SL, Fowler MS, Healy K, Jackson AL, Lurgi M, McClean D, O'Connor NE, O'Gorman EJ, Yang Q. Donohue I, et al. Among authors: jackson al. Ecol Lett. 2016 Sep;19(9):1172-85. doi: 10.1111/ele.12648. Epub 2016 Jul 19. Ecol Lett. 2016. PMID: 27432641 Review.
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Whelan K, Dillon M, Strickland KC, Pothuri B, Bae-Jump V, Borden LE, Thaker PH, Haight P, Arend RC, Ko E, Jackson AL, Corr BR, Ayoola-Adeola M, Wright JD, Podwika S, Smitherman C, Thomas S, Lightfoot M, Newton M, Washington C, Mullen M, Cosgrove C, Harsono AAH, Powell K, Herzog TJ, Salani R, Alvarez Secord A. Whelan K, et al. Among authors: jackson al. Gynecol Oncol. 2023 Nov;178:44-53. doi: 10.1016/j.ygyno.2023.09.009. Epub 2023 Sep 23. Gynecol Oncol. 2023. PMID: 37748270
The mutation rate and cancer.
Jackson AL, Loeb LA. Jackson AL, et al. Genetics. 1998 Apr;148(4):1483-90. doi: 10.1093/genetics/148.4.1483. Genetics. 1998. PMID: 9560368 Free PMC article. Review.
How will RNAi facilitate drug development?
Bartz S, Jackson AL. Bartz S, et al. Among authors: jackson al. Sci STKE. 2005 Aug 2;2005(295):pe39. doi: 10.1126/stke.2952005pe39. Sci STKE. 2005. PMID: 16077085 Review.
Hidden reach of the micromanagers.
Linsley PS, Jackson AL. Linsley PS, et al. Among authors: jackson al. BMC Biol. 2010 May 11;8:53. doi: 10.1186/1741-7007-8-53. BMC Biol. 2010. PMID: 20529236 Free PMC article. Review.
185 results